Comparative efficacy and safety of first-line treatments in patients with metastatic renal cell cancer: a network meta-analysis based on phase 3 RCTs

It is impossible to conduct head-to-head trials of all the therapies to determine optimal treatment in the rapidly advancing era of therapies for metastatic renal cell carcinoma (mRCC). In this network meta-analysis,we aimed to compare efficacy and safety of first-line treatments for mRCC. We search...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Xiaofeng, Zhang, Fan, Liu, Tieshi, Yang, Rong, Ji, Changwei, Zhao, Xiaozhi, Xu, Linfeng, Liu, Guangxiang, Guo, Hongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941278/
https://www.ncbi.nlm.nih.gov/pubmed/26908455
http://dx.doi.org/10.18632/oncotarget.7511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941278/
https://www.ncbi.nlm.nih.gov/pubmed/26908455
http://dx.doi.org/10.18632/oncotarget.7511

Ejemplares similares